Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 33.02 | N/A |
| PEG Ratio (TTM) | 17.74 | N/A |
| P/S Ratio (TTM) | 6.92 | N/A |
| P/B Ratio (TTM) | -170.22 | N/A |
| P/FCF Ratio (TTM) | 29.31 | N/A |
| Price to 5YR AVG Earnings Ratio | 39.50 | N/A |
| Price to 5YR AVG FCF Ratio | 36.81 | N/A |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 23.97% | N/A |
| ROE (TTM) | -516.84% | N/A |
| Net Profit Margin (TTM) | 21.15% | N/A |
| ROIC 5YR AVG | 56.11% | N/A |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 2.60% | 18.20% | 12.86% |
| Revenue | 0.33% | 8.51% | 5.52% |
| Net Income | 2.01% | 14.82% | 9.67% |
| Cash Flow | 2.11% | 17.44% | 11.85% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.01 | N/A |
| Quick Ratio (TTM) | 0.69 | N/A |
| D/E Ratio (TTM) | -13.46 | N/A |
| Interest Coverage (TTM) | 14.78 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 10.09 | N/A |
| LTL to 5YR AVG FCF | 2.79 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.83% | N/A |